Persones / Equip Humà

Anna Planavila Porta

Buscador de publicacions

Publicacions

  • Peyman M, Babin-Ebell A, Rodríguez-Rodríguez R, Rigon M, Aguilar-Recarte D, Villarroya-Terrade J, Planavila A, Villarroya-Gombau F, Palomer FX, Barroso E and Vazquez M.

    SIRT1 regulates hepatic vldlr levels

    CELL COMMUNICATION AND SIGNALING . 22(1): 297-297. Nº de cites: 1

    [doi:10.1186/s12964-024-01666-y]

  • Morón S, Blasco-Roset A, Navarro-Gascon A, Rupérez CH, MATIAS ZAMORA RODRÍGUEZ, Fàtima Crispi Brillas, Uriarte I, Fernández-Barrena MG, Avila M, Ferrer-Curriu G, Lupón J, Bayés-Genis A, Villarroya-Gombau F, Gavaldà-Navarro A and Planavila A.

    A new FGF15/19-mediated gut-to-heart axis controls cardiac hypertrophy.

    JOURNAL OF PATHOLOGY . 261(3): 335-348. Nº de cites: 2

    [doi:10.1002/path.6193]

  • Curriu GF, Rued F, López ER, García CG, Codina P, Montón CG, Roura S, Aimo A, Emdin M, Planavila A and Genís AB.

    Meteorin-like protein is associated with a higher risk profile and predicts a worse outcome in patients with STEMI.

    REVISTA ESPANOLA DE CARDIOLOGIA . 76(11): 891-900. Nº de cites: 4

    [doi:10.1016/j.rec.2023.03.015]

  • Ruperez C, Blasco-Roset A, Kular D, Cairo M, Ferrer-Curriu G, Villarroya-Terrade J, MATIAS ZAMORA RODRÍGUEZ, Fàtima Crispi Brillas, Villarroya-Gombau F and Planavila A.

    Autophagy is Involved in Cardiac Remodeling in Response to Environmental Temperature Change.

    FRONTIERS IN PHYSIOLOGY . 13: 864427-864427. Nº de cites: 7

    [doi:10.3389/fphys.2022.864427]

  • Rupérez CH, Ferrer-Curriu G, Cervera-Barea A, Florit L, Guitart-Mampel M, Garrabou G, MATIAS ZAMORA RODRÍGUEZ, Fàtima Crispi Brillas, Fernandez-Solà J, Lupón J, Bayes-Genis A, Villarroya-Gombau F and Planavila A.

    Meteorin-like/Meteorin-ß protects heart against cardiac dysfunction.

    JOURNAL OF EXPERIMENTAL MEDICINE . 218(5): 20201206. Nº de cites: 40

    [doi:10.1084/jem.20201206]

  • Ferrer-Curriu G, Guitart-Mampel M, Rupérez CH, MATIAS ZAMORA RODRÍGUEZ, Fàtima Crispi Brillas, Villarroya-Gombau F, Fernández-Solà J, Garrabou G and Planavila A.

    The protective effect of fibroblast growth factor-21 in alcoholic cardiomyopathy: a role in protecting cardiac mitochondrial function.

    JOURNAL OF PATHOLOGY . 253(2): 198-208. Nº de cites: 22

    [doi:10.1002/path.5573]

  • Barroso E, Rodríguez-Rodríguez R, Zarei M, Pizarro-Degado J, Planavila A, Palomer FX, Villarroya-Gombau F and Vazquez M.

    SIRT3 deficiency exacerbates fatty liver by attenuating the HIF1 alpha-LIPIN 1 pathway and increasing CD36 through Nrf2

    CELL COMMUNICATION AND SIGNALING . 18(1): 147-147. Nº de cites: 27

    [doi:10.1186/s12964-020-00640-8]

  • Palomer FX, Román-Azcona MS, Pizarro J, Planavila A, Villarroya-Gombau F, Valenzuela-Alcaraz BI, Crispi F, Sepúlveda-Martínez Á, Miguel-Escalada I, Ferrer J, Nistal JF, García R, Davidson MM, Barroso E and Vazquez M.

    SIRT3-mediated inhibition of FOS through histone H3 deacetylation prevents cardiac fibrosis and inflammation.

    signal transduction and targeted therapy . 5(1): 14-14. Nº de cites: 111

    [doi:10.1038/s41392-020-0114-1]

  • Ferrer-Curriu G, Redondo-Angulo I, Guitart-Mampel M, Ruperez C, Mas-Stachurska A, Sitges M, Garrabou G, Villarroya-Gombau F, Fernández-Solà J and Planavila A.

    Fibroblast growth factor-21 protects against fibrosis in hypertensive heart disease.

    JOURNAL OF PATHOLOGY . 248(1): 30-40. Nº de cites: 38

    [doi:10.1002/path.5226]

  • Rupérez CH, Lerin C, Ferrer-Curriu G, Cairo M, Mas-Stachurska A, Sitges M, Villarroya-Terrade J, Giralt M, Villarroya-Gombau F and Planavila A.

    Autophagic control of cardiac steatosis through FGF21 in obesity-associated cardiomyopathy

    INTERNATIONAL JOURNAL OF CARDIOLOGY . 260: 163-170. Nº de cites: 34

    [doi:10.1016/j.ijcard.2018.02.109]